...
首页> 外文期刊>Progress in Cardiovascular Diseases >Use of m-Health Technology for Preventive Interventions to Tackle Cardiometabolic Conditions and Other Non-Communicable Diseases in Latin America- Challenges and Opportunities
【24h】

Use of m-Health Technology for Preventive Interventions to Tackle Cardiometabolic Conditions and Other Non-Communicable Diseases in Latin America- Challenges and Opportunities

机译:使用M-Health Technology进行预防性干预措施,以解决拉丁美洲的心脏浮动条件和其他非传染性疾病 - 挑战和机遇

获取原文
获取原文并翻译 | 示例

摘要

In Latin America, cardiovascular disease (CVD) mortality rates will increase by an estimated 145% from 1990 to 2020. Several challenges related to social strains, inadequate public health infrastructure, and underfinanced healthcare systems make cardiometabolic conditions and non-communicable diseases (NCDs) difficult to prevent and control. On the other hand, the region has high mobile phone coverage, making mobile health (mHealth) particularly attractive to complement and improve strategies toward prevention and control of these conditions in low- and middle-income countries. In this article, we describe the experiences of three Centers of Excellence for prevention and control of NCDs sponsored by the National Heart, Lung, and Blood Institute with mHealth interventions to address cardiometabolic conditions and other NCDs in Argentina, Guatemala, and Peru. The nine studies described involved the design and implementation of complex interventions targeting providers, patients and the public. The rationale, design of the interventions, and evaluation of processes and outcomes of each of these studies are described, together with barriers and enabling factors associated with their implementation. (C) 2016 Elsevier Inc. All rights reserved.
机译:在拉丁美洲,心血管疾病(CVD)死亡率将从1990年到2020年增加145%。与社会菌株,公共卫生基础设施不足和不通用的医疗保健系统有几种挑战,使心细差异和非传染性疾病(NCDS)难以预测和控制。另一方面,该地区具有高手机覆盖范围,使移动健康(MHECHEATH)具有尤其吸引力,以补充和改进预防和控制低收入和中等收入国家这些条件的策略。在本文中,我们描述了由国家心脏,肺和血液研究所提出的保健干预措施,以解决阿根廷,危地马拉和秘鲁的Cartiabolic条件和其他NCD,为预防和控制NCD的三个卓越中心的经验。所描述的九项研究涉及复杂干预措施的设计和实施目标,患者,患者和公众。描述的理由,设计的干预和评估这些研究的过程和结果以及与其实施相关的障碍和能力。 (c)2016年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号